Evaluating the Technology and Assessing the Biological Effects of Commercially Available PhotoBioModulation Devices
NCT: NCT06403644 · ACTIVE_NOT_RECRUITING
Brief Summary
Photobiomodulation therapy (PBMT) involves applying non-ionizing forms of light from sources including lasers, LEDs, and broadband light, in the visible and near infrared spectrum, to the body to enhance performance, stimulate healing, modulate recovery, and improve health. The investigators will conduct a single-blinded randomized-control trial with sham control to investigate the effectiveness of providing PBMT in a military population, translating this cutting-edge research to application in the operational setting.
Frequently Asked Questions
What is Evaluating the Technology and Assessing the Biological Effects of Commercially Available PhotoBioModulation Devices?
Evaluating the Technology and Assessing the Biological Effects of Commercially Available PhotoBioModulation Devices is a clinical trial registered under NCT06403644. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT06403644?
The current status of NCT06403644 (Evaluating the Technology and Assessing the Biological Effects of Commercially Available PhotoBioModulation Devices) is: ACTIVE_NOT_RECRUITING.
When did Evaluating the Technology and Assessing the Biological Effects of Commercially Available PhotoBioModulation Devices start?
Evaluating the Technology and Assessing the Biological Effects of Commercially Available PhotoBioModulation Devices started on 2024-03-11.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.